IFNA1 and cancer: In summary, we find that APR-246 disables the mtp53-mediated tumour cells evasion from immune surveillance either via upregulation of the IFN pathway or via downregulation of inhibitory immune checkpoints, depending on the mechanisms of immune escape in a particular type of cancer cells.